mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾

OAÈë¿Ú
±¨¸æµ¥ÅÌÎÊ
ÔÚÏ߿ͷþ
mg±ùÇòÍ»ÆÆ(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÐÂÎÅÖÐÐÄ
News Center
ÄêÇáµÄÄãÈôÊÇÈȰ®Ô˶¯£¬ÇëÎñ±ØÐ¡ÐÄÕâÖÖÐÄÔ༲²¡
Ðû²¼£º2023/06/14

ÄãºÍÄãÉí±ßµÄÅóÙ­ÃÇ£¬ÊÇ·ñÓÐÅÜÍê²½ÐØ¿ÚÌÛ£¬´òÍêÇòÐĻš¢ÐØÃƵÄÇéÐΣ¿ÕâЩ֢״£¬»òÐíÊÇÄãµÄÐÄÔàÕýÔÚÇÃÏ쿵½¡µÄ¡°¾¯ÖÓ¡±¡£


42.jpg

ÓÐÒ»ÖÖÒÔÐÄÊұڷʺñΪÖ÷ÒªÌØÕ÷µÄµ¥»ùÒòÒÅ´«ÐÔÐÄÔ༲²¡£¬³ÆÎª·ÊºñÐÍÐ¡£¨hypertrophic cardiomyopathy, HCM£©¡£ÕâÖÖ¼²²¡µÄÆð²¡¡¢Ï£ÍûÒþÄ䣬ÄêÇỼÕßÍùÍùûÓÐÈκÎÐÄÔàÖ¢×´£¬Í¨ÀýÐÄÔà¼ì²éЧ¹û¿ÉÄÜÒ²ÎÞÒì³££¬µ«»¼Õß¼«Ò×ÔÚÔ˶¯Ê±ÓÉÓÚÐÄÔàÇ¿ÁÒÔ˶¯ÒýÆðÐÄÔ´ÐÔâ§ËÀ£¨SCD£©¡£


ƾ֤ʵÄá°¢²¨Àû˹ÐÄÔàÑо¿Ëù»ù½ð»á£¨MHIF£©Êý¾ÝÏÔʾ£¬ÔÚÃÀ¹ú£¬Ã¿Á½ÖܾÍÓÐÒ»Ãû¸ßÖС¢´óѧ»òÖ°ÒµÔË·¢¶¯ËÀÓÚHCMÏà¹ØµÄÐÄÔ´ÐÔâ§ËÀ¡£Òò´Ë£¬½øÒ»²½Ìá¸ß¹«ÖÚ¶ÔHCMÔçÆÚÖ¢×´µÄÈÏ֪ˮƽ£¬ÌáÉýHCMÔçÆÚÁÙ´²ÕïÁÆÄÜÁ¦¾ßÓÐÖ÷ÒªÒâÒå¡£


±àÂëÐ¡Ð¡½ÚÏà¹ØÂѰ׵ĻùÒòÏÖÒѱ»¹«ÈÏÊÇHCMµÄ½¹µãÖ²¡»ùÒò£¬ÈçMYBPC3£¬MYH7£¬MYL2/3µÈ¡£Í¨¹ý»ùÒò¼ì²â·¢Ã÷ÕâЩÖ²¡»ùÒò±äÒì״̬ÊÇʵÏÖHCMÔçÆÚɸ²é¡¢ÔçÆÚÕï¶Ï¼°¾«×¼Ò½ÁƵÄÒªº¦Í¾¾¶¡£

ͼƬ 2.png


2023Äê6ÔÂ4ÈÕ£¬mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾ÓëÏÃÃÅ´óѧÁ¥ÊôÐÄѪ¹Ü²¡Ò½ÔººÏ×÷£¬ÔÚÅ·ÖÞÐÄÔಡѧ»áÆìÏÂÆÚ¿¯¡¶ESC Heart Failure¡·£¨IF=3.6£©£¬½ÒÏþÁËÌâΪ¡°A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy¡±µÄÑо¿ÂÛÎÄ¡£¸ÃÑо¿ÔÚÁÙ´²ÐÄÔ๦Ч¼ì²é»ù´¡ÉÏ£¬ÍŽá»ùÒòÈ«ÍâÏÔ×Ó×é²âÐò£¨whole-exome sequencing, WES£©¡¢Sanger·¨²âÐò¼ì²âÊÖÒÕ£¬ÔÚÒ»¸öî¾»¼HCM/SCDµÄ¼Ò×åÖУ¬Õ¹ÏÖÁËÒ»¸öÐ¡ÇòÂѰ×ÍŽáÂѰ×c »ùÒòMYBPC3 c.1522C>TÔӺϴíÒåÍ»±äÓëHCMµÄÏà¹ØÐÔ£¬Îª³ä·ÖÊìϤMYBPC3 c.1522C>TµÄÖ²¡ÐÔÌṩÁËÖ÷ÒªÁÙ´²Ö¤¾Ý¡£



HCMÁÙ´²ÌåÏÖ

±¾´ÎÑо¿ÆÊÎöÁ˸üÒϵ4´úÈË£¬ÆäÖÐÏÈÖ¤Õߣ¨¢ò-9, 65Ë꣩µÄÖ÷ÒªÁÙ´²ÌåÏÖ°üÀ¨£º

ÐØ²¿ÌÛÍ´£º³£ÓÚÀÍÀÛ¡¢Ô˶¯ºó±¬·¢£¬ÐÝÏ¢ºó»º½â¡£

Æø¶Ì¡¢ºôÎüÄÑÌ⣺²»Ã÷Ôµ¹ÊÔ­ÓÉ£¬×ÝÈ»ÉÔ΢»î¶¯Ê±Ò²»á·ºÆð¡£

Òâʶ¶ÌÔÝËðʧ£ºÍ»·¢ÇÒ¶ÌÔݵÄÔÎØÊ£¬Ò»Á¬¼¸Ê®ÃëÖÁÊý·ÖÖÓ¡£




HCM¼Ò×åÊ·

ͼƬ 3.png

ÏÈÖ¤Õߵĸç¸ç£¨¢ò-4£©ºÍÖ¶×Ó£¨¢ó-3£©ÒÑÖªÒòSCD²»ÐÒÀëÊÀ£¬ºóÕßÒ²ÔøÈ·ÕïHCM¡£ÏÈÖ¤ÕßâïÊÑÒÑÀëÊÀ£¬µ«ÏêϸԵ¹ÊÔ­Óɲ»Ïê¡£


HCM±¬·¢²¿Î»

ͼƬ 4.png

ÐÄÔà´Å¹²Õñ³ÉÏñÃ÷È·ÏÈÖ¤ÕßÐļ¡·Êºñ²¿Î»Ö÷Òª±¬·¢ÓÚ»ùµ×²¿½üǰ±Ú¾àÀëÁÚ£¨19 mm£©£¬»ùµ×²¿½üϱھàÀëÁÚ£¨14 mm£©£¬Öв¿½üǰ±Ú¾àÀëÁÚ£¨20 mm£©£¬Öв¿½üϱھàÀëÁÚ£¨17.5 mm£©¡£


HCMÖ²¡»ùÒò


WES·¢Ã÷ÏÈÖ¤ÕßMYBPC3»ùÒòµÚ16ºÅÍâÏÔ×Ó±£´æc.1522C>TÔӺϴíÒåÍ»±ä£¬ÎªÒÑÖªHCMÖ²¡±äÒì¡£MYBPC3»ùÒò±àÂëÐ¡ÇòÂѰ×ÍŽáÂѰ×c£¬ÊÇHCM×î³£¼ûµÄÖ²¡»ùÒò¡£MYBPC3 c.1522C>T¿ÉÄܻᱬ·¢½Ø¶ÏµÄÂѰ×ÖÊ£¬Ëðº¦Ð¡ÇòÂѰ×Ëõ¶Ì¹¦Ð§£¬´Ó¶øµ¼ÖÂHCM¡£



MYBPC3»ùÒò±äÒìɸ²é

ʹÓÃSanger·¨²âÐòÑо¿Ö°Ô±½øÒ»²½È·ÈÏÁ˼¸Î»¿µ½¡¼ÒÍ¥³ÉÔ±¾ùδЯ´øMYBPC3 c.1522C>T£¬°üÀ¨ÏÈÖ¤Õß¶ù×Ó£¨¢ó-5£©£¬Ëï×Ó£¨¢ô-5£©£¬ËïÅ®£¨¢ô-6£©¼°ÔøÖ¶×Ó£¨¢ô-3£©¡£È»¶ø£¬ÏÈÖ¤Õß¿µ½¡µÄÔøÖ¶Å®£¨¢ô-4, 18Ë꣩ȴͬÑùЯ´øMYBPC3 c.1522C>TÔӺϴíÒåÍ»±ä¡£ËäÈ»£¬MYBPC3 c.1522C>TµÄÖ²¡ÐÔ¿ÉÄÜÔÚ²î±ð¸öÌåÖб£´æÒìÖÊÐÔ£¬²¢·×Æç¶¨»áµ¼ÖÂÆäÔøÖ¶Å®î¾»¼HCM£¬µ«Ë¼Á¿µ½¸Ã¼Ò×åÖÐÃ÷È·µÄHCM/SCD¼Ò×åÊ·£¬ÑϿᰴÆÚ¸´²éÐÄÔ๦ЧÈÔÊ®·ÖÖ÷Òª¡£


×ÛÉÏËùÊö£¬±¾´ÎÑо¿Ê¹ÓûùÒò¼ì²âÊÖÒÕ£¬Ê×´ÎÔÚÖйúHCM/SCD¼Ò×åÖз¢Ã÷ÁËMYBPC3 c.1522C>TÔӺϴíÒåÍ»±ä£¬ÕâÔÚÃ÷È·Ïà¹ØHCM»¼ÕßÒÅ´«Ñ§²¡ÒòµÄͬʱ£¬Ò²Í¹ÏÔÁ˼Ò×å»ùÒò¼ì²âÔÚHCM»¼ÕßµÄÔçɸ¡¢ÔçÕï¡¢ÔçÖÎÖеÄÖ÷ÒªÐÔ¡£




ÒÅ´«ÐÅÏ¢µÄ¼ì²âÓë½â¶ÁÊǾ«×¼Ò½Ñ§µÄ½¹µã£¬¶øÐÂÒ»´ú»ùÒò²âÐò£¨NGS£©ÊÇÆÆÒëÒÅ´«ÐÅÏ¢×îΪÖ÷ÒªµÄÊֶΡ£


mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾NGSÖÐÐÄÑÏ¿áÆ¾Ö¤ISO15189ÈϿɺÍÃÀ¹úCAPÈÏÖ¤ÒªÇó¾ÙÐÐʵÑéÊÒ±ê×¼ºÍ¹æ·¶µÄ¹ÜÀí£¬¾ß±¸Ñù±¾¼ì²â¡¢ÉúÐÅÆÊÎö¡¢±¨¸æ½â¶Á¡¢ÒÅ´«×Éѯ¡¢×ÔÖ÷Ñз¢µÈ×ÛºÏÄÜÁ¦£¬Æð¾¢¼ÓÈë²¢¸ßˮƽͨ¹ýNCCL¡¢CAP¡¢EMQN¶àÏî¸ßͨÁ¿²âÐòÊÒ¼äÖÊÆÀ¡£

ÖÐÐÄ¿ª·¢ÁË»ùÓÚÈ«ÍâÏÔ×Ó¡¢¼ÒϵȫÍâÏÔ×ÓÒÔ¼°È«»ùÒò×é²âÐòÆÊÎöÓëÒÅ´«²¡ÆÊÎöÁ÷³Ì£¬Äܹ»Íê³ÉÖÖÖÖÒÅ´«ÐÔ¼²²¡µÄɸ²éÓëÕï¶Ï£¬°üÀ¨ÒÅ´«ÐÔÖ×Áö¡¢ÒÅ´«ÐÔÐÄѪ¹Ü¼²²¡¡¢ÒÅ´«ÐÔÑÛ²¡¡¢ÒÅ´«ÐÔÆ¤·ô²¡¡¢ÒÅ´«ÐÔÄÚÉøÍ¸²¡¡¢ÒÅ´«ÐԹDz¡¡¢ÒÅ´«ÐÔÉñ¾­ÐÔ¼²²¡¡¢ÒÅ´«ÐÔ´úл²¡µÈ£¬¹²10¸ö´óÀàÔ¼6000ÓàÖÖÒÅ´«ÐÔ¼²²¡¡£


mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾NGSÖÐÐĽ«¼ÌÐøÒԸ߱ê×¼¡¢ÑÏÒªÇ󹿷¶Ã¿Ò»ÀýÑù±¾µÄ¼ì²â£¬Ò»Èç¼ÈÍùµØÑÏ¿á°Ñ¿Ø¸÷¸ö¼ì²â»·½Ú£¬ÖúÁ¦ÓÚ¸ßЧºÍ¸öÐÔ»¯ÖÎÁƼƻ®µÄÑ¡Ôñ£¬Îª¾«×¼Ò½ÁƵÄʵÏÖТ˳Á¦Á¿£¬ÎªÊµÏÖ¡°ÈùúÈËÒ»ÂɵطÖÏí¿µ½¡¡±µÄʹÃü¶ø²»Ð¸Æð¾¢¡£



ÍøÕ¾µØÍ¼